Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Fukui

Showing results (821-830 of 831) with videos related to

Pageof 84
Sort By:
Diabetic Medicine : a Journal of the British Diabetic Association|February 1, 1997
Antibodies to glutamic acid decarboxylase in Japanese diabetic patients with secondary failure of oral hypoglycaemic therapyM Fukui, K Nakano, H Shigeta, et al.
Neurosurgical Focus|December 5, 2006
Combined chemotherapy and radiation therapy for central nervous system germ cell tumors: preliminary results of a Phase II study of the Japanese Pediatric Brain Tumor Study GroupM Matsutani, Y Ushio, H Abe, et al.
Free Radical Biology & Medicine|August 30, 2000
Induction of aldose reductase in cultured human microvascular endothelial cells by advanced glycation end productsN Nakamura, H Obayashi, M Fujii, et al.
Human Immunology|November 24, 1999
Influence of TNF microsatellite polymorphisms (TNFa) on age-at-onset of insulin-dependent diabetes mellitusH Obayashi, N Nakamura, M Fukui, et al.
Biochemical and Biophysical Research Communications|September 4, 1996
Formation of crossline as a fluorescent advanced glycation end product in vitro and in vivoH Obayashi, K Nakano, H Shigeta, et al.
Journal of Clinical Immunology|February 25, 1998
HLA-DRB1 alleles contribute to determining the prognosis of Japanese diabetes mellitus positive for antibodies to glutamate decarboxylaseM Fukui, K Nakano, N Nakamura, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|September 1, 1981
[A clinical study on the effect of K-708 (acemetacin)--a double blind comparative study with ibuprofen in upper respiratory tract inflammation with fever (author's transl)]O Kitamoto, H Kobayashi, M Kaji, et al.
ESMO Open|May 27, 2026
Effect of prior anti-EGFR therapy and baseline ctDNA profiling on the efficacy of pertuzumab plus trastuzumab in HER2-amplified metastatic colorectal cancer: an integrated analysis of TRIUMPH/MyPathwayY Matsubara, M Wakabayashi, W Okamoto, et al.
International Journal of Molecular Medicine|December 16, 1998
Inhibition in a microgravity environment of the recovery of Escherichia coli cells damaged by heavy ion beams during the NASDA ISS phase I program of NASA Shuttle/Mir mission no. 6K Harada, T Sugahara, T Ohnishi, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
VOLTAGE-2: multicenter phase II study of nivolumab monotherapy in patients with mismatch repair-deficient resectable locally advanced rectal cancerH Bando, Y Tsukada, S Kumagai, et al.
Pageof 84

Showing results (821-830 of 831) with videos related to

Sort By:
Pageof 84
Diabetic Medicine : a Journal of the British Diabetic Association|February 1, 1997
Antibodies to glutamic acid decarboxylase in Japanese diabetic patients with secondary failure of oral hypoglycaemic therapyM Fukui, K Nakano, H Shigeta, et al.
Neurosurgical Focus|December 5, 2006
Combined chemotherapy and radiation therapy for central nervous system germ cell tumors: preliminary results of a Phase II study of the Japanese Pediatric Brain Tumor Study GroupM Matsutani, Y Ushio, H Abe, et al.
Free Radical Biology & Medicine|August 30, 2000
Induction of aldose reductase in cultured human microvascular endothelial cells by advanced glycation end productsN Nakamura, H Obayashi, M Fujii, et al.
Human Immunology|November 24, 1999
Influence of TNF microsatellite polymorphisms (TNFa) on age-at-onset of insulin-dependent diabetes mellitusH Obayashi, N Nakamura, M Fukui, et al.
Biochemical and Biophysical Research Communications|September 4, 1996
Formation of crossline as a fluorescent advanced glycation end product in vitro and in vivoH Obayashi, K Nakano, H Shigeta, et al.
Journal of Clinical Immunology|February 25, 1998
HLA-DRB1 alleles contribute to determining the prognosis of Japanese diabetes mellitus positive for antibodies to glutamate decarboxylaseM Fukui, K Nakano, N Nakamura, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|September 1, 1981
[A clinical study on the effect of K-708 (acemetacin)--a double blind comparative study with ibuprofen in upper respiratory tract inflammation with fever (author's transl)]O Kitamoto, H Kobayashi, M Kaji, et al.
ESMO Open|May 27, 2026
Effect of prior anti-EGFR therapy and baseline ctDNA profiling on the efficacy of pertuzumab plus trastuzumab in HER2-amplified metastatic colorectal cancer: an integrated analysis of TRIUMPH/MyPathwayY Matsubara, M Wakabayashi, W Okamoto, et al.
International Journal of Molecular Medicine|December 16, 1998
Inhibition in a microgravity environment of the recovery of Escherichia coli cells damaged by heavy ion beams during the NASDA ISS phase I program of NASA Shuttle/Mir mission no. 6K Harada, T Sugahara, T Ohnishi, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
VOLTAGE-2: multicenter phase II study of nivolumab monotherapy in patients with mismatch repair-deficient resectable locally advanced rectal cancerH Bando, Y Tsukada, S Kumagai, et al.
Pageof 84